Pulse Biosciences, Inc. PLSE Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Operating margin | -21,982.6%— | —— | —— | -8,188.6%— | |
| Net margin | -20,794.6%— | —— | —— | -8,251.8%— | |
| Returns | |||||
| Return on equity | -74.4%-7.1pp | -67.3%— | —— | —— | |
| Return on invested capital | -1,168.1%-411pp | -757.1%-338pp | -419.1%+97.8pp | -516.9%-130pp | |
| Efficiency | |||||
| Asset turnover | 0×— | 0×— | 0×0.0× | 0×— | |
| Liquidity | |||||
| Current ratio | 10.5×-1.4× | 11.9×+5.1× | 6.8×-3.6× | 10.4×+3.6× | |
| Leverage | |||||
| Debt-to-equity | 0.1×0.0× | 0.1×-0.1× | 0.2×— | —— | |
| Valuation | |||||
| Market capitalization | $930.45M-13.1% | $1.07B+58.9% | $673.91M+553% | $103.12M-76.6% | |
| Price / sales | 2,658.4×— | —— | —— | 145.5×— | |
| Price / book | 11.5×+2.2× | 9.3×-5.9× | 15.2×— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pulse Biosciences, Inc.'s profit margins?
- Pulse Biosciences, Inc. (PLSE) runs a -4067.5% gross margin and a -10392.1% operating margin, with a -9929.0% net margin.
- Where do Pulse Biosciences, Inc.'s ratios come from?
- Every ratio is computed from Pulse Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
